Cover Image
市場調查報告書

醫藥品噴霧乾燥市場

Pharmaceutical Spray Drying Market, 2014 - 2024

出版商 ROOTS ANALYSIS 商品編碼 306162
出版日期 內容資訊 英文 146 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品噴霧乾燥市場 Pharmaceutical Spray Drying Market, 2014 - 2024
出版日期: 2014年06月24日 內容資訊: 英文 146 Pages
簡介

一般認為醫藥品噴霧乾燥產業全體超過10億美元的規模。噴霧乾燥技術廣用於醫藥品產業的醫藥品原料。可是噴霧乾燥的商用藥物還只有數個案例。大型製藥公司已經為了在公司內部設置噴霧乾燥設備進行著投資,不過現有的設備可能無法對應未來的需求。

本報告提供醫藥品領域的噴霧乾燥相關技術廣泛調查、醫藥品原料的製造中噴霧乾燥技術的未來趨勢、與傳統技術的比較、應用領域、市場2013∼2024年的預測等彙整。

第1章 序論

第2章 摘要整理

第3章 噴霧乾燥:概要

  • 簡介
  • 噴霧乾燥流程
    • 原料準備
    • 原料的乾燥
    • 分離
  • 噴霧乾燥的應用
  • 競爭環境

第4章 市場概要

  • 概要
  • 醫藥品噴霧烘乾機廠商
  • 已上市噴霧烘乾機的競爭分析
  • 公司內部設備
  • 已上市藥物:給藥法分析

第5章 噴霧烘乾機廠商:簡介

  • 概要
  • GRA-Niro
  • SPX
  • Buchi Labortechnik
  • Hemraj India
  • 其他

第6章 CMO分析

  • 簡介
  • 能力分析
  • 容量分析
  • 各地區分析
  • CMO簡介
    • Hovione
    • Bend Research
    • Upperton
    • Nova Laboratories

第7章 應用

  • 簡介
    • 改善藥物的溶解性及生物有效性的噴霧乾燥
    • 吸入劑的噴霧乾燥
    • 微膠囊化
    • 生技藥品的噴霧乾燥

第8章 未來市場預測

  • 概要
  • 方法
  • 假設
  • 方案的結果
  • 比較摘要

第9章 案例研究:疫苗

  • 概要
  • 已上市疫苗:廣為使用的冷凍乾燥
    • 流感疫苗
    • PATH流感疫苗計劃
    • 備考

第10章 SWOT分析

第11章 採訪概要

第12章 結論

第13章 附錄1:表格形式資料

第14章 附錄2:企業清單

圖表

目錄
Product Code: RA10016

The concept of ‘spray drying' started in late 19th century in the food and chemical industry. Within pharmaceutical industry, spray drying found its use initially for the production of APIs. The technology has not been used as widely for commercial drug formulations yet. We have come across only limited examples of marketed drugs for which spray drying is used for developing the commercial batches. The future growth in the market will primarily be driven by aseptic spray drying, which allows production of biologics and vaccines. The process, being suitable for heat-sensitive products, is likely to find acceptance for drying of biologics. This will help eliminate the requirement for cold chains and refrigeration, saving not just the cost of maintaining such processes, but also prevent the costs associated with drug batches which lose integrity due to cold chain challenges.

Both freeze drying and spray drying methods are based on the concept of solvent evaporation. However, unlike freeze drying that only allows solvent evaporation, a major advantage of spray drying is that it helps manipulate the particle size of powdered drugs. It is an efficient, economical and a relatively more stable method of drying. The single step process of drying also helps improve the compression properties of drugs, allowing drug developers to reduce the number of pills or tablet size. This can help improve patient compliance or be used for life cycle management for drugs nearing patent expiry.

Big pharmaceutical companies, such as GSK and Janssen, have established in-house facilities for commercial production of their spray dried drugs. There is widespread optimism that the pharmaceutical spray drying market is likely to witness double digit growth in the future. Given that currently majority of the market is driven by lyophilization, it is highly likely that the growth in spray drying market is going to come from the pipeline of drugs rather than existing marketed drugs themselves. CMOs, specifically, are expected to play a leading role in the industry's evolution; many have already invested in developing capabilities to meet the demand of clients.

Synopsis:

The “Pharmaceutical Spray Drying Market, 2014-2024” report provides an extensive study on the emergence of spray drying in the pharmaceutical sector. The focus of this report is primarily to understand the likely future evolution of spray drying for manufacturing of Active Pharmaceutical Ingredients (APIs), inhalables, injectables, biologics and other affiliated products. When compared to conventional drying techniques, spray drying offers multiple advantages such as improved particle size distribution, improved solubility and bioavailability, enhanced taste and relatively more stable end products.

The report covers various aspects such as applications of spray drying, manufacturing / product landscape, CMOs active in spray drying, key growth drivers and the upcoming opportunities for various industry stakeholders. In fact, one of the key objectives of this report is to understand how popular is spray drying expected to become in the pharma industry over the course of next ten years. Based upon our research and discussions with industry stakeholders, we believe the technology will continue to strengthen its position in the pharma industry and gain a growing share of the market in the coming years. For the purposes of our analysis, we have looked at various scenarios that could unfold in the future; these scenarios represent different tracks of industry evolution and help us understand the potential of spray drying based upon wider developments across the industry.

The base year for the report is 2013. The report provides short-mid term and long term market forecasts for the period 2013 - 2018 and 2018 - 2024, respectively. The research, analysis and insights presented in this report include the growth of the overall pharma drying market distributed by spray drying, lyophilization and other drying technologies. The figures mentioned in this report are in USD, unless otherwise specified.

Example Highlights

  • 1. Spray drying has been used extensively for APIs in the pharmaceutical industry; however, there are only a few examples of spray dried commercial drugs. These include Intelence, Kalydeco, Incivek, and Zortress.
  • 2. Specific to the pharmaceutical industry, there are around 50 models of spray dryers which are currently available worldwide. These models offer variation in the scale of operation (laboratory / pilot / industrial), evaporation rate, inlet air temperature and other technical parameters. The market is highly consolidated, with Niro and Buchi being the most preferred equipment providers.
  • 3. CMOs have successfully identified the potential of this market, making requisite investments in the field to add spray drying to their portfolio or expand their capacities. We have identified around 40 contract manufacturers which are currently offering spray drying services for drugs and biologics.
  • 4. Aseptic spray drying is likely to be one of the key focus areas in this sector. Not many companies are currently developing aseptic spray dryers or providing commercial aseptic spray drying services. The situation, though, is likely to change in the near-term.
  • 5. Big pharma companies, such as, GSK, Janssen, Novartis have already invested in establishing in-house spray drying facilities. However, the existing installed capacity is likely to fall short of the growing demand in the future.
  • 6. The overall pharma spray drying industry could grow beyond USD 1 billion in a few years' time; this will be driven to a certain extent by the overall growth of the biopharmaceuticals' market. Emergence of new technologies / applications is likely to provide the necessary impetus to fuel further growth.

Research Methodology

Most of the data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

While the focus has been on forecasting the market over the coming ten years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

Chapter Outlines

Chapter 2 provides an executive summary of the insights captured in our research. The summary offers a high level view on where the pharmaceutical spray drying market is headed in the mid-long term.

Chapter 3 provides a general introduction to the spray drying. We have discussed, in detail the concepts behind spray drying and its applications and advantages.

Chapter 4 provides an overview of the spray drying market. The chapter offers details on the important parameters involved in spray drying (e.g., inlet air temperature, nozzle type, atomization gas used etc.). It also details the in house spray drying capabilities of top pharmaceutical companies.

Chapter 5 presents profiles of spray dryer manufacturers for pharmaceutical companies. Amongst other insights, the chapter discusses the technical details, financial information and relevant recent partnerships for respective companies.

Chapter 6 includes an analysis of the contract manufacture ring organizations (CMOs) active in the spray drying market. We have done a high level capacity, capability and regional analysis for CMOs. We have also profiled the top leading CMOs in this area providing details on their current product portfolio, recent collaborations and other relevant information.

Chapter 7 provides details of the applications of spray drying. Each application is supported by examples. The applications include the microencapsulation of the drug, taste masking, enhancing bioavailability and solubility.

Chapter 8 presents a scenario based approach to identify the future evolution of the pharma spray drying market. The forecast over the next ten year time period highlight the market's overall potential and is based upon detailed insights gathered from discussions with industry stakeholders.

Chapter 9 is a case study on vaccines with a focus on the use of drying technology, including spray drying. We have studied the influenza vaccine to understand advantages of spray drying the vaccines.

Chapter 10 provides our analysis of the strengths, weaknesses, opportunities and threats in the spray drying market, capturing the key elements likely to influence future growth.

Chapter 11 is a compilation of interview transcripts; these discussions have helped us understand the key market dynamics, competitive landscape and the likely future trends in the industry.

Chapter 12 summarizes the overall report. In this chapter, we provide a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.

Chapters 13 and 14 are appendices, which provide the list of companies and tabulated data for all the figures presented in the report.

SAMPLE

Figure 5.2 - CMO Landscape: Distribution by the Spray Dryer Used

Source: Roots Analysis

               Note: A particular CMO may use more than one company's spray dryer;
                  such instances have been counted separately

Table of Contents

1. PREFACE

  • 1.1 Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. SPRAY DRYING: AN OVERVIEW

  • 3.1. Introduction
  • 3.2. The Process of Spray Drying
    • 3.2.1. Feed Preparation
    • 3.2.2. Drying of the Feed Material
    • 3.2.3. Separation
  • 3.3. Applications of Spray Drying: A Primer
  • 3.4. Competitive Landscape

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. Pharma Spray Dryer Manufacturers
  • 4.3. Competitive Analysis of Marketed Spray Dryers
    • 4.3.1. Scale of Operation
    • 4.3.2. Rate of Evaporation
    • 4.3.3. Inlet Temperature
    • 4.3.4. Atomizing Gas
    • 4.3.5. Nozzle Type
  • 4.4. In-house Facilities
  • 4.5. Marketed Drugs: Dosage Form Analysis

5. SPRAY DRYER MANUFACTURERS: PROFILES

  • 5.1. Chapter Overview
  • 5.2. GEA- Niro
    • 5.2.1. Company Overview
    • 5.2.2. Spray Dryers: Product Portfolio
    • 5.2.3. Key Features
    • 5.2.4. Interest of CMOs
    • 5.2.5. Recent Partnerships / Collaborations
      • 5.2.5.1. Pfizer & G-Con
      • 5.2.5.2. Molecular Profiles
      • 5.2.5.3. Technical University of Denmark (DTU)
      • 5.2.5.4. BASF
      • 5.2.5.5. International Specialty Products (ISP)
    • 5.2.6. Manufacturing Facility
    • 5.2.7. Financial Information
    • 5.2.8. Future Outlook
  • 5.3. SPX
    • 5.3.1. Company Overview
    • 5.3.2. Spray Dryers: Product Portfolio
    • 5.3.3. Key Features
      • 5.3.3.1. Anhydro Micra Standard Spray Dryers
      • 5.3.3.2. Anhydro Micra GMP Spray Dryers
      • 5.3.3.3. Anhydro MicraSpray A-Class Series
      • 5.3.3.4. Anhydro MicraSpray Aseptic Series
    • 5.3.4. Aseptic Spray Drying for Tuberculosis
    • 5.3.5. Recent Partnerships / Collaborations
    • 5.3.6. Manufacturing Facility
    • 5.3.7. Financial Information
    • 5.3.8. Future Outlook
  • 5.4. Buchi Labortechnik
    • 5.4.1. Company Overview
    • 5.4.2. Spray Dryers: Product Portfolio
    • 5.4.3. B-290 Spray Dryer
    • 5.4.4. B-90 Spray Dryer
    • 5.4.5. Interest of CMOs
    • 5.4.6. Partnerships / Collaborations
      • 5.4.6.1. GEA Niro
      • 5.4.6.2. Sono-Tek
    • 5.4.7. Future Outlook
  • 5.5. Hemraj India
    • 5.5.1. Company Overview
    • 5.5.2. Spray Dryers: Product Portfolio
    • 5.5.3. Product Profiles
      • 5.5.3.1. Laboratory Spray Dryers
      • 5.5.3.2. Pilot Scale Spray Dryers
      • 5.5.3.3. Industrial Scale Spray Dryers
    • 5.5.4. Future Outlook
  • 5.6. Other Spray Dryer Manufacturers
    • 5.6.1. Labultima
    • 5.6.2. Advanced Drying Systems
    • 5.6.3. Spray Drying Systems
    • 5.6.4. Raj Process Equipment
    • 5.6.5. Siegfried
    • 5.6.6. ProCepT
    • 5.6.7. Techni Process

6. CMO ANALYSIS

  • 6.1. Introduction
  • 6.2. Capability Analysis
    • 6.2.1. Fill/ Finish Capability Analysis
  • 6.3. Capacity Analysis
  • 6.4. Regional Analysis
    • 6.4.1. Laboratory/ Clinical Scale
    • 6.4.2. Development Scale
    • 6.4.3. Industrial/ Commercial Scale
  • 6.5. CMO Profiles
    • 6.5.1. Hovione
      • 6.5.1.1. Company Overview
      • 6.5.1.2. Historical Background
      • 6.5.1.3. Partnerships
      • 6.5.1.4. Historical Sales
    • 6.5.2. Bend Research
      • 6.5.2.1. Company Overview
      • 6.5.2.2. Historical Background
      • 6.5.2.3. Partnerships
      • 6.5.2.4. Future Outlook
    • 6.5.3. Upperton
      • 6.5.3.1. Company Overview
      • 6.5.3.2. Historical Background
      • 6.5.3.3. Partnerships
    • 6.5.4. Nova Laboratories
      • 6.5.4.1. Company Overview
      • 6.5.4.2. Historical Background
      • 6.5.4.3. VitRIS and HydRIS
      • 6.5.4.4. Future Plans

7. APPLICATIONS

  • 7.1. Introduction
    • 7.1.1. Spray Drying to Improve the Solubility & Bioavailability of the Drug
    • 7.1.2. Spray Drying of Inhalable Drugs
    • 7.1.3. Microencapsulation
    • 7.1.4. Spray Drying of Biologics

8. FUTURE MARKET OUTLOOK

  • 8.1. Overview
  • 8.2. Methodology
  • 8.3. Key Assumptions
  • 8.4. Scenario Results
    • 8.4.1. The Bearish Scenario
    • 8.4.2. The Stable Scenario
    • 8.4.3. The Bullish Scenario
    • 8.4.4. The Ambitious Scenario
  • 8.5. Comparative Summary

9. CASE STUDY: VACCINES

  • 9.1. Chapter Overview
  • 9.2. Marketed Vaccines: Extensive Use of Lyophilization
    • 9.2.1. Influenza Vaccine
      • 9.2.1.1. Historical Usage
      • 9.2.1.2. Stringent Storage Requirements
      • 9.2.1.3. Cases of Cold Chain Failure
      • 9.2.1.4. Evaluation of Drying Technology
    • 9.2.2. PATH Influenza Vaccine Project
    • 9.2.3. Remarks

10. SWOT ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Strengths
  • 10.3. Weaknesses
  • 10.4. Opportunities
  • 10.5. Threats

11. INTERVIEW TRANSCRIPTS

12. CONCLUSION

  • 12.1. Spray Drying: Slow to Pickup
  • 12.2. Consolidated Market Landscape; Unlikely to Change in the Future
  • 12.3. Emergence of New Technologies
  • 12.4. CMOs Likely to Play a Pivot Role
  • 12.5. Overall Opportunity is Big; We Project a 20% Annual Growth in the Bullish Scenario

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES

List of Figures:

  • Figure 4.1: Pharma Spray Dryer Manufacturers: Number of Spray Dryers
  • Figure 4.2: CMOs: Split by Spray Dryers Used
  • Figure 4.3: Spray Dryers: Distribution by Scale of Operation
  • Figure 4.4: Spray Dryers: Distribution by Water Evaporation Rate
  • Figure 4.5: Spray Dryers: Distribution by Inlet Temperature
  • Figure 4.6: Spray Dryers: Distribution by Atomization Gas
  • Figure 4.7: Spray Dryers: Distribution by Nozzle Type
  • Figure 4.8: Marketed Drugs: Distribution by Method of Formulation
  • Figure 5.1: GEA-Niro: Portfolio of Spray Dryers
  • Figure 5.2: CMO Landscape: Distribution by the Spray Dryer Used
  • Figure 5.3: GEA Revenues, 2009-2013 (EUR Million)
  • Figure 5.4: GEA Revenues, 2013: Distribution by Industry Segment
  • Figure 5.5: SPX: Portfolio of Key Spray Dryers
  • Figure 5.6: SPX Revenues, 2009-2013 (USD Million)
  • Figure 5.7: SPX Revenues: Distribution by Business Segment (USD Million)
  • Figure 6.1: Regional Presence of CMOs (Laboratory Scale)
  • Figure 6.2: Regional Presence of CMOs (Development Scale)
  • Figure 6.3: Regional Presence of CMOs (Commercial Scale)
  • Figure 6.4: Hovione: Historic Timeline
  • Figure 6.5: Bend Research: Historic Timeline
  • Figure 6.6: Upperton: Historic Timeline
  • Figure 6.7: Nova Laboratories: Historic Timeline
  • Figure 8.1: Future Market Scenarios: Description
  • Figure 8.2: Total Drying Market: Future Evolution under ‘Bearish' Scenario, Short - Mid Term, 2013 - 2018 (USD Million)
  • Figure 8.3: Total Drying Market: Future Evolution under ‘Bearish' Scenario, Long Term, 2018 - 2024 (USD Million)
  • Figure 8.4: Spray Drying Market: Growth Rates under ‘Bearish' Scenario (%)
  • Figure 8.5: Total Drying Market: Future Evolution under ‘Stable' Scenario, Short - Mid Term, 2013 - 2018 (USD Million)
  • Figure 8.6: Total Drying Market: Future Evolution under ‘Stable' Scenario, Long Term, 2018 - 2024 (USD Million)
  • Figure 8.7: Spray Drying Market: Growth Rates under ‘Stable' Scenario (%)
  • Figure 8.8: Total Drying Market: Future Evolution under ‘Bullish' Scenario, Short - Mid Term, 2013 - 2018 (USD Million)
  • Figure 8.9: Total Drying Market: Future Evolution under ‘Bullish' Scenario, Long Term, 2018 - 2024 (USD Million)
  • Figure 8.10: Spray Drying Market: Growth Rates under ‘Bullish' Scenario (%)
  • Figure 8.11: Total Drying Market: Future Evolution under ‘Ambitious' Scenario, Short - Mid Term, 2013 - 2018 (USD Million)
  • Figure 8.12: Total Spray Dying Market: Future Evolution under ‘Ambitious' Scenario, Long Term, 2018 - 2024 (USD Million)
  • Figure 8.13: Spray Drying Market: Growth Rates under ‘Ambitious' Scenario (%)
  • Figure 8.14: Market Scenarios: Comparative Positioning (USD Billion)
  • Figure 8.15: Market Scenarios: Comparative Annual Growth Rates
  • Figure 9.1: US Marketed Vaccines: Distribution by Formulation Methods
  • Figure 9.2: Units of Influenza Vaccine Sold in the US, 2010-2013 (Million)
  • Figure 9.3: Sales Data of Top Five Influenza Vaccines
  • Figure 9.4: Causes of Cold Chain Failure
  • Figure 10.1: Number of Patents Issued for Hot Melt Extrusion: 1983-2005

List of Tables:

  • Table 3.1: Types of Atomizers Used in Spray Dryers
  • Table 3.2: Spray Dryer: Modes of Operation
  • Table 3.3: Comparison of Spray Drying and Freeze Drying
  • Table 4.1: Technical Specifications of Marketed Spray Dryers
  • Table 4.2: Spray Dryer Comparison: Laboratory, Pilot and Commercial Scales
  • Table 4.3: Top Pharmaceutical Companies: Availability of In-house Spray Drying Facility
  • Table 4.4: New Drug Launches 2008-2013: Distribution by Formulation Method
  • Table 4.5: Marketed Drugs: Spray Drying v/s Melt Methods
  • Table 5.1: GEA-Niro: Key Characteristics of Spray Dryers
  • Table 5.2: List of CMOs using Niro Spray Dryers
  • Table 5.3: SPX: Key Characteristics of MicraSpray Dryers
  • Table 5.4: SPX: Other Spray Dryers
  • Table 5.5: SPX: Business Segments
  • Table 5.6: Buchi: Key Characteristics of Spray Dryers
  • Table 5.7: Buchi Spray Dryers: Supplementary Instruments
  • Table 5.8: CMOs using Buchi Spray Dryers
  • Table 5.9: Hemraj India: Key Characteristics of Spray Dryers
  • Table 5.10: Pharma Companies Using Hemraj's GLS-1000 Spray Dryers
  • Table 5.11: Pharma Companies Using Hemraj's Pilot Scale Spray Dryers
  • Table 6.1: CMO Capability Analysis
  • Table 6.2: CMO Capacity Analysis
  • Table 6.3: List of CMOs and Geographical Locations
  • Table 7.1: List of Spray Dried Drugs: To Improve Solubility and Bioavailability
  • Table 7.2: List of Spray Dried Inhalable Drugs
  • Table 7.3: Polymers Used for Microencapsulation
  • Table 7.4: Polymers Used for Controlled and Immediate Release
  • Table 7.5: List of Spray Dried Drugs: For Taste Masking
  • Table 7.6: List of Spray Dried Drugs: For Sustained Delivery
  • Table 7.7: List of Other Spray Dried Biologics
  • Table 9.1: List of Vaccines Marketed in the US: By Method of Formulation
  • Table 9.2: List of Spray Dried Vaccines Under Development
  • Table 9.3: List of Some Marketed Influenza Vaccines: Storage Requirements
  • Table 9.4: Pandemic Influenza Vaccines in Market
  • Table 9.5: Spray Dried Influenza Vaccine: Stability and Delivery Route
  • Table 9.6: PATH Collaboration for Spray Drying
  • Table 10.1: Pharmaceutical Spray Drying: SWOT Analysis
  • Table 10.2: Marketed Vaccines: Final Formulation
  • Table 10.3: List of CMOs Active in Spray Drying
  • Table 13.1: Pharma Spray Dryer Manufacturers: Number of Spray Dryers
  • Table 13.2: CMOs: Split by Spray Dryer Used
  • Table 13.3: Spray Dryers: Distribution by Scale of Operation
  • Table 13.4: Spray Dryers: Distribution by Water Evaporation Rate
  • Table 13.5: Spray Dryers: Distribution by Inlet Temperature
  • Table 13.6: Spray Dryers: Distribution by Atomization Gas
  • Table 13.7: Spray Dryers: Distribution by Nozzle Type
  • Table 13.8: Marketed Drugs: Distribution by Method of formulation
  • Table 13.9: GEA Revenues, 2009-2013 (EUR Million)
  • Table 13.10: SPX Revenues, 2009-2013 (USD Million)
  • Table 13.11: SPX Revenues: Distribution by Business Segment (USD Million)
  • Table 13.12: Total Drying Market: Future Evolution under ‘Bearish' Scenario, Short-Mid Term, 2013-2018 (USD Million)
  • Table 13.13: Total Drying Market: Future Evolution under ‘Bearish' Scenario, Long Term, 2018-2024 (USD Million)
  • Table 13.14: Spray Drying Market: Growth Rates under ‘Bearish Scenario'
  • Table 13.15: Total Drying Market: Future Evolution under ‘Stable' Scenario, Short-Mid Term, 2013-2018 (USD Million)
  • Table 13.16: Total Drying Market: Future Evolution under ‘Stable' Scenario, Long Term, 2018-2024 (USD Million)
  • Table 13.17: Spray Drying Market: Growth Rates under ‘Stable' Scenario
  • Table 13.18: Total Drying Market: Future Evolution under ‘Bullish', Short-Mid Term, 2013-2018 (USD Million)
  • Table 13.19: Total Drying Market: Future Evolution under ‘Bullish', Long Term, 2018-2024 (USD Million)
  • Table 13.20: Spray Drying Market: Growth Rates under ‘Bullish' Scenario
  • Table 13.21: Total Drying Market: Future Evolution under ‘Ambitious', Short-Mid Term, 2013-2018 (USD Million)
  • Table 13.22: Total Drying Market: Future Evolution under ‘Ambitious', Long Term, 2018-2024 (USD Million)
  • Table 13.23: Spray Drying Market: Growth Rates under ‘Ambitious' Scenario
  • Table 13.24: Marketed Vaccines: Distribution by Formulation Method
  • Table 13.25: Units of Influenza Vaccine Sold, 2010-2013
  • Table 13.26: Sales Data of Top 5 Influenza Vaccine
  • Table 13.27: Causes of Cold Chain Failure

List of Companies:

The following companies and organizations have been mentioned in the report.

  • 1. AbbVie
  • 2. Advance Cyclone Systems
  • 3. Advanced Drying Systems
  • 4. Aesica Pharmaceuticals
  • 5. Agere Pharma
  • 6. Aizant
  • 7. Al Fiha'a Company
  • 8. Albion
  • 9. Almac Group
  • 10. Amgen
  • 11. AMRI Global
  • 12. Aptuit
  • 13. Aridis Pharmaceuticals
  • 14. Ascendia Pharma
  • 15. Astellas
  • 16. AstraZeneca
  • 17. Astron Research
  • 18. Avestha Gengraine
  • 19. BASF
  • 20. Baxter
  • 21. Bayer
  • 22. Bend Research
  • 23. Biogen Idec
  • 24. Bristol Myers Squibb
  • 25. Boehringer Ingelheim
  • 26. Buchi
  • 27. Capsugel
  • 28. Cipla Ltd.
  • 29. Claris Life sciences Ltd.
  • 30. Corilis Pharma
  • 31. Crucell, Aeras
  • 32. CSL Ltd
  • 33. Daiichi Sankyo
  • 34. Dalavan
  • 35. Dr. Reddy's Laboratories
  • 36. Drytec Contract Processing
  • 37. Drytech India
  • 38. Eisai
  • 39. Eli Lilly
  • 40. Evonik
  • 41. Formex LLC
  • 42. Formurex
  • 43. Fuji Chemical Industry
  • 44. G-CON
  • 45. Gilead Sciences
  • 46. GlaxoSmithKline
  • 47. Glenmark Pharmaceutical Ltd.
  • 48. Green Cross
  • 49. GSK
  • 50. Hemraj India
  • 51. Hovione
  • 52. ID Biomedical Corporation of Quebec
  • 53. IDI Farma
  • 54. Inn Biotechnologia Sa
  • 55. Janssen Pharmaceuticals
  • 56. Kuecept
  • 57. Labquip (S) PTE. Ltd.
  • 58. Labultima
  • 59. Ligand Pharmaceuticals
  • 60. MedImmune
  • 61. Meggle Pharma
  • 62. Merck
  • 63. Metrics, Inc.
  • 64. Micro-sphere SA
  • 65. Molecular Profiles
  • 66. NanoBio Group
  • 67. Niro
  • 68. North Star Processing
  • 69. Norwich Pharmaceuticals
  • 70. Nova Labs
  • 71. Novartis
  • 72. Novo Nordisk
  • 73. Novozymes
  • 74. Ohkawara Kakohki
  • 75. Otsuka
  • 76. Panacea Biotec Ltd.
  • 77. Particle Sciences
  • 78. Patheon Inc.
  • 79. Pfizer
  • 80. Pharma Spray Drying
  • 81. Pharmaceutics International
  • 82. PharmaForm
  • 83. Pharmatek Laboratories
  • 84. Pharmaterials Ltd.
  • 85. PowderJect
  • 86. ProCepT
  • 87. Protein Sciences
  • 88. Pulse Combustion Systems
  • 89. Raj Process Equipment
  • 90. Ranbaxy Laboratories Ltd.
  • 91. Roche
  • 92. RSIL Ltd.
  • 93. Sandoz India Ltd.
  • 94. Sanofi Pasteur
  • 95. Seigfried
  • 96. Shantha Biotechnics
  • 97. Sinovac
  • 98. Solvias
  • 99. Sono-Tek
  • 100. Spray Drying Systems
  • 101. Spraying Systems Co
  • 102. Spray-Tek
  • 103. SPX
  • 104. Sun Pharmaceuticals Ltd.
  • 105. Synbias Pharma Ltd.
  • 106. Techni Process
  • 107. Torrent Pharmaceuticals
  • 108. Ufag Laboratorien
  • 109. Upperton-Aesica
  • 110. USV Ltd.
Back to Top